Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENICE: Nevirapine Dosing Strategy After Efavirenz Withdrawal
NCT00704249Phase 4Completed
- Sponsor
- Clinical Trial Agency of HIV Study Group
- Start
- Jul 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Clinical Trial Agency of HIV Study Group. Started Jul 2006; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00704249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00704249.